Cellectis (ADR) (CLLS)
Develops gene-edited allogeneic CAR-T candidates and manufacturing capabilities.
$1.56
After hours−0.01 (−0.64%)
At close$1.57(+3.97%)
Something off on this page? Send us feedback.
Next report
Nov 13, 26
estimated · in 52 days
EPS estimate
−$0.18
Revenue estimate
$15.6M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.16−$0.18−$0.24$0.01−$0.26−$0.18−$0.22Pending
Estimate$0.06−$0.19−$0.10−$0.10−$0.20−$0.26−$0.26−$0.18
Surprise−366.7%+5.3%−140.0%+110.0%−27.9%+30.3%+16.3%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$12.7M$10.7M$16.9M$35.2M$12.2M$7.5M$6.9MPending
Estimate$9.2M$12.7M$8.2M$10.3M$13.4M$11.0M$11.0M$15.6M
Surprise+38.7%−16.2%+106.0%+242.4%−8.9%−31.6%−37.5%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | −$0.11 | — | — |
| Sep 2027 | −$0.12 | — | — |
| Jun 2027 | −$0.27 | — | — |
| Mar 2027 | −$0.30 | — | — |
| Dec 2026 | −$0.20 | — | — |
| Nov 2026 | −$0.18 | — | — |
| Aug 2026 | −$0.26 | −$0.22 | +16.3% |
| May 2026 | −$0.26 | −$0.18 | +30.3% |
| Mar 2026 | −$0.20 | −$0.26 | −27.9% |
| Nov 2025 | −$0.10 | $0.01 | +110.0% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| Apr 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Sep 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Sep 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | −$0.11 | — | — | $36.3M | — | — | — |
| Sep 2027 | −$0.12 | — | — | $31.4M | — | — | — |
| Jun 2027 | −$0.27 | — | — | $35.5M | — | — | — |
| Mar 2027 | −$0.30 | — | — | $26.5M | — | — | — |
| Dec 2026 | −$0.20 | — | — | $20.8M | — | — | — |
| Nov 13, 2026 | −$0.18 | — | — | $15.6M | — | — | — |
| Aug 6, 2026 | −$0.26 | −$0.22 | +16.3% | $11.0M | $6.9M | −37.5% | +5.6% |
| May 11, 2026 | −$0.26 | −$0.18 | +30.3% | $11.0M | $7.5M | −31.6% | −0.5% |
| Mar 19, 2026 | −$0.20 | −$0.26 | −27.9% | $13.4M | $12.2M | −8.9% | −4.0% |
| Nov 7, 2025 | −$0.10 | $0.01 | +110.0% | $10.3M | $35.2M | +242.4% | +11.3% |
| Aug 4, 2025 | |||||||
| May 12, 2025 | |||||||
| Mar 13, 2025 | |||||||
| Nov 4, 2024 | |||||||
| Aug 6, 2024 | |||||||
| Apr 29, 2024 | |||||||
| Mar 11, 2024 | |||||||
| Nov 6, 2023 | |||||||
| Aug 3, 2023 | |||||||
| May 4, 2023 | |||||||
| Mar 8, 2023 | |||||||
| Nov 3, 2022 | |||||||
| Aug 4, 2022 | |||||||
| May 12, 2022 | |||||||
| Mar 3, 2022 | |||||||
| Nov 4, 2021 | |||||||
| Aug 5, 2021 | |||||||
| May 6, 2021 | |||||||
| Mar 4, 2021 | |||||||
| Nov 5, 2020 | |||||||
| Aug 5, 2020 | |||||||
| May 6, 2020 | |||||||
| Mar 4, 2020 | |||||||
| Nov 6, 2019 | |||||||
| Aug 6, 2019 | |||||||
| May 7, 2019 | |||||||
| Mar 11, 2019 | |||||||
| Nov 13, 2018 | |||||||
| Aug 1, 2018 | |||||||
| May 7, 2018 | |||||||
| Mar 12, 2018 | |||||||
| Nov 13, 2017 | |||||||
| Aug 2, 2017 | |||||||
| May 9, 2017 | |||||||
| Mar 6, 2017 | |||||||
| Nov 22, 2016 | |||||||
| Sep 8, 2016 | |||||||
| May 11, 2016 | |||||||
| Mar 16, 2016 | |||||||
| Nov 19, 2015 | |||||||
| Sep 9, 2015 |